Bright Minds Biosciences Inc (DRUG) Stock Price, Quote & News

Company Profile

Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies. The company also develo...

Industry: Biotechnology

Sector: Healthcare

Phone: 647 865 8622

Website: brightmindsbio.com

Address:

19 Vestry Street, New York, United States

MavrickPete Sep. 7 at 8:32 PM

$DRUG need a bounce tomorrow

0 · Reply

Wody Sep. 2 at 11:39 PM

$ALLR next $DRUG run?!

1 · Reply

CoffeeRocks Sep. 1 at 9:35 PM

$SGLD $INHD $APUS $DRUG See under 10$ 🔜

0 · Reply

CoffeeRocks Aug. 31 at 5:22 PM

$AIFF buys are here $DRUG $INHD AIFF 1$ to $$$$

0 · Reply

mktrdr59 Aug. 29 at 10:45 PM

$DRUG approaching possible confluence of support just under $70, including the measured move projection from the Aug 19 high, the 1.618 external retracement of wave b, the .618 retracement of the Jun 16 - Aug 19 rally, & possible support from the Jul 29 low.

0 · Reply

JustAguysOpinion Aug. 27 at 12:07 AM

$TNXP 😆 yes. So I come into tnxp mid November 2024. Entered 0.15 then really loaded 0.14. Missed 1.90 but got 1.50s and 1.30s. When that one happen it was not set up lile this. This time has way way more institutions. Insiders for the 1st time buying outside of their package. Especially Seth, he has never done that. The big one here tho is the % short. It was bot 25%. This bad boy is a mega nuke if it does swueeze again. Can $DRUG. Going to be a fun 6 months here. Q1 2027 should be 🔥 tho I am hoping the right groups see the situation our short friends got into. They so bet on a bad earnings, tonix crushing it and institutions eating it up set it up hella good. Just hope it happens, to date going good

0 · Reply

ShawnDBG Aug. 25 at 12:36 AM

$DAIC $DRUG seems to think so

0 · Reply

theflynews Aug. 20 at 3:33 PM

Psychedelic: Enveric, Helus, Bright Minds report earnings results - $DRUG - https://thefly.com/DRUG

0 · Reply

JFDI Aug. 19 at 11:56 PM

The same pattern that showed in bahh $MRNA is showin’ up in any $DRUG ‘s $FATE & The Return of the Desc Wedge. The Measured Move on the Desc Wedge is where the pattern originated. Yes, jus scribblin’ & dribblin’

0 · Reply

Doozio Aug. 19 at 10:00 PM

$DRUG zzzzz are next.

1 · Reply

Bright Minds Biosciences to Present at Upcoming Conferences

Aug 14, 2026, 6:20 PM EDT - 4 weeks ago

Bright Minds Biosciences Registration statement: Q3 2026

Aug 14, 2026, 6:20 PM EDT - 4 weeks ago

Bright Minds Biosciences Registration statement: Q3 2026

Fri, 31 Jul 2026 08:30:00 -0400 - 6 weeks ago

Vistagen Appoints Douglas J. Williamson to its Board of Directors

2026-07-07T13:55:00.000Z - 2 months ago

New Options Listings: Bright Minds Biosciences (DRUG)

Jun 3, 2026, 4:20 PM EDT - 3 months ago

Bright Minds Biosciences Transcript: Jefferies Global Healthcare Conference 2026

Tue, 26 May 2026 19:18:00 -0400 - 3 months ago

Bright Minds Biosciences to Present at Jefferies Global Healthcare Conference

2026-05-21T21:31:11.000Z - 3 months ago

Why a $5 Million New Position Signals Confidence in This Epilepsy Drug Pipeline

2026-05-20T10:45:58.000Z - 3 months ago

Bright Minds price target raised to $220 from $190 at Piper Sandler

DRUG

May 19, 2026, 4:00 PM EDT - 3 months ago

Bright Minds Biosciences Registration statement: Q2 2026

May 19, 2026, 4:00 PM EDT - 3 months ago

Bright Minds Biosciences Registration statement: Q2 2026

2026-04-13T13:55:38.000Z - 5 months ago

DRUG Initiates Coverage On Bright Minds Biosciences -- Price Target Announced

2026-04-12T23:20:16.000Z - 5 months ago

Bright Minds initiated with a Buy at Jefferies

2026-03-04T20:00:37.000Z - 6 months ago

Bright Minds Biosciences Inc at TD Cowen Healthcare Conference Transcript

Mar 4, 2026, 9:10 AM EST - 6 months ago

Bright Minds Biosciences Transcript: TD Cowen 46th Annual Health Care Conference

2026-03-04T13:39:47.000Z - 6 months ago

Bright Minds price target raised to $145 from $115 at H.C. Wainwright

Wed, 25 Feb 2026 16:30:00 -0500 - 6 months ago

Bright Minds Biosciences to Present at Upcoming Conferences

2026-02-17T11:31:20.000Z - 6 months ago

BTIG Maintains Buy Rating for Bright Minds Biosciences (DRUG) with $147 Target | DRUG Stock News

2026-02-13T14:21:13.000Z - 7 months ago

Bright Minds price target lowered to $126 from $142 at Baird

Feb 11, 2026, 6:00 PM EST - 7 months ago

Bright Minds Biosciences Registration statement: Q1 2026

Feb 11, 2026, 6:00 PM EST - 7 months ago

Bright Minds Biosciences Registration statement: Q1 2026

Fri, 09 Jan 2026 11:56:00 -0500 - 8 months ago

Bright Minds Biosciences Announces Closing of US$175 Million Public Offering

2026-01-08T07:57:10.000Z - 8 months ago

Bright Minds Biosciences (DRUG) Prices $175M Public Offering

Wed, 07 Jan 2026 21:33:00 -0500 - 8 months ago

Bright Minds Biosciences Announces Pricing of Upsized US$175 Million Public Offering of Common Stock

2026-01-07T13:05:22.000Z - 8 months ago

Bright Minds Biosciences, Praxis Precision Medicines And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

2026-01-07T13:00:57.000Z - 8 months ago

Bright Minds price target raised to $142 from $82 at Baird

2026-01-07T11:46:42.000Z - 8 months ago

Bright Minds price target raised to $147 from $72 at BTIG

2026-01-06T21:11:24.000Z - 8 months ago

Bright Minds announces $100M common shares offering

Tue, 06 Jan 2026 16:00:00 -0500 - 8 months ago

Bright Minds Biosciences Announces Launch of US$100 Million Public Offering

2026-01-06T18:31:59.000Z - 8 months ago

BTIG Raises Price Target for Bright Minds Biosciences (DRUG) to $147 | DRUG Stock News

2026-01-06T18:00:09.000Z - 8 months ago

Bright Minds Biosciences Inc BMB-101 Topline data announcement Transcript

Tue, 06 Jan 2026 11:52:33 -0500 - 8 months ago

New Bright Minds Epilepsy Drug Cuts Seizures, Lifts Stock On Tuesday

2026-01-06T15:07:53.000Z - 8 months ago

Microchip Technology, Alumis, Terrestrial Energy, Bright Minds Biosciences And Other Big Stocks Moving Higher On Tuesday

2026-01-06T13:00:04.000Z - 8 months ago

Bright Minds Biosciences (DRUG) Surges on Successful Trial Results

Jan 6, 2026, 8:00 AM EST - 8 months ago

Bright Minds Biosciences Transcript: Study Result

Jan 6, 2026, 8:00 AM EST - 8 months ago

Bright Minds Biosciences Press release: Study Result

Jan 6, 2026, 8:00 AM EST - 8 months ago

Bright Minds Biosciences Slides: Study Result

2026-01-06T12:25:21.000Z - 8 months ago

Bright Minds announces results from Phase 2 BREAKTHROUGH trial of BMB-101

Tue, 06 Jan 2026 07:16:00 -0500 - 8 months ago

Bright Minds Biosciences Announces Positive Topline Results from Phase 2 Clinical Trial of BMB-101 in Patients with Absence Seizures and Developmental and Encephalopathic Epilepsies (DEE)

2026-01-06T09:04:44.000Z - 8 months ago

Bright Minds To Unveil Topline Results For BMB-101 Phase 2 Trial In Absence Seizures And DEE

Mon, 05 Jan 2026 16:30:00 -0500 - 8 months ago

Bright Minds to Announce Topline Results for BMB-101 Phase 2 Trial in Absence Seizures and Developmental and Epileptic Encephalopathies on Tuesday, January 6, 2026

Jan 4, 2026, 7:00 AM EST - 8 months ago

Bright Minds Biosciences Slides: Corporate Presentation

2026-01-02T13:30:17.000Z - 8 months ago

Bright Minds Biosciences (DRUG) Maintains Buy Rating with $80 Price Target | DRUG Stock News

2025-12-30T16:00:54.000Z - 8 months ago

Bright Minds Biosciences (DRUG) Sees Stable Analyst Rating Today | DRUG Stock News

Dec 23, 2025, 7:00 AM EST - 8 months ago

Bright Minds Biosciences Registration statement: Q4 2025

Dec 23, 2025, 7:00 AM EST - 8 months ago

Bright Minds Biosciences Registration statement: Q4 2025

Dec 23, 2025, 7:00 AM EST - 8 months ago

Bright Minds Biosciences Annual report: Q4 2025

Nov 25, 2025, 4:30 PM EST - 9 months ago

Bright Minds Biosciences to Present at Piper Sandler 37th Annual Healthcare Conference and 2025 AES Annual Meeting

Mon, 17 Nov 2025 17:29:36 -0500 - 9 months ago

Why Bright Minds Biosciences Stock Topped the Market on Monday

Nov 17, 2025, 6:50 AM EST - 10 months ago

Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Experts in Prader-Willi Syndrome (PWS)

Nov 12, 2025, 9:00 AM EST - 10 months ago

Bright Minds Biosciences Transcript: Guggenheim Securities 2nd Annual Healthcare Innovation Conference

2025-11-07T12:25:38.000Z - 10 months ago

Bright Minds price target raised to $82 from $75 at Baird

Nov 6, 2025, 10:00 AM EST - 10 months ago

Bright Minds Biosciences Transcript: KOL Event

Nov 6, 2025, 10:00 AM EST - 10 months ago

Bright Minds Biosciences Press release: KOL Event

Nov 6, 2025, 6:30 AM EST - 10 months ago

Bright Minds Biosciences Initiates New Prader-Willi Syndrome (PWS) Program; KOL Event Scheduled for November 6TH

Nov 5, 2025, 6:00 PM EST - 10 months ago

Bright Minds Biosciences Slides: Corporate Presentation

2025-09-08T09:55:04.000Z - 1 year ago

Bright Minds initiated with a Buy at BTIG

2025-09-04T12:35:25.000Z - 1 year ago

Bright Minds says BMB-201 outperforms sumatriptan in preclinical model

Aug 26, 2025, 8:00 AM EDT - 1 year ago

Bright Minds Biosciences Registration statement: Registration Filing

Aug 13, 2025, 6:00 PM EDT - 1 year ago

Bright Minds Biosciences Registration statement: Q3 2025

Aug 13, 2025, 6:00 PM EDT - 1 year ago

Bright Minds Biosciences Registration statement: Q3 2025

May 20, 2025, 8:00 AM EDT - 1 year ago

Bright Minds Biosciences Announces Featured Speakers for its Absence Epilepsy Virtual R&D Day on May 20, 2025

May 16, 2025, 4:00 PM EDT - 1 year ago

Bright Minds Biosciences Registration statement: Q2 2025

May 16, 2025, 4:00 PM EDT - 1 year ago

Bright Minds Biosciences Registration statement: Q2 2025

May 13, 2025, 4:00 PM EDT - 1 year ago

Bright Minds Biosciences Press release: Study Update

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Bright Minds Biosciences to Host Virtual R&D Day on May 20, 2025; Program Highlights Include an Overview of Absence Seizures and the BMB-101 Phase 2 Study

Feb 14, 2025, 4:00 PM EST - 1 year ago

Bright Minds Biosciences Registration statement: Q1 2025

Feb 14, 2025, 4:00 PM EST - 1 year ago

Bright Minds Biosciences Registration statement: Q1 2025

Feb 5, 2025, 7:00 AM EST - 1 year ago

Bright Minds Biosciences Registration statement: Registration Filing

Jan 7, 2025, 6:50 AM EST - 1 year ago

Bright Minds Biosciences Appoints Pharmaceutical Leader, Stephen Collins, M.D., Ph.D., as Chief Medical Officer

Dec 30, 2024, 4:00 PM EST - 1 year ago

Bright Minds Biosciences Annual report: Q4 2024

Wed, 13 Nov 2024 12:59:00 -0500 - 1 year ago

Meet the Biotech Stock That Has Generated Nvidia-Like Returns in Less Than a Month

Nov 4, 2024, 2:41 PM EST - 1 year ago

Bright Minds Biosciences Closes US$35 Million Non-Brokered Private Placement

Oct 28, 2024, 8:21 AM EDT - 1 year ago

PESG Releases Market Update: Nuvectis Pharma Shows Promising Synergy for NXP900 in Recent Presentations; Growing Anticipation for Upcoming NXP800 Data Update

NVCT

Oct 21, 2024, 8:30 AM EDT - 1 year ago

Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data

Oct 18, 2024, 6:50 AM EDT - 1 year ago

Bright Minds Biosciences Announces US$35 Million Non-Brokered Private Placement

Oct 16, 2024, 4:00 PM EDT - 1 year ago

Bright Minds Biosciences Press release: Study Update

Oct 16, 2024, 10:45 AM EDT - 1 year ago

Bright Minds Biosciences proprietary compound, BMB-201, 5-HT2C/2A mixed agonist, demonstrated similar efficacy to morphine in preclinical pain models

Oct 16, 2024, 8:46 AM EDT - 1 year ago

Bright Minds Biosciences Stock Surges Almost 1,500%

Oct 16, 2024, 5:57 AM EDT - 1 year ago

Biotech stock tumbles after unexplained 1,446% gain

Oct 15, 2024, 9:09 PM EDT - 1 year ago

Bright Minds is Unaware of Any Material Changes

Oct 3, 2024, 9:00 AM EDT - 1 year ago

Bright Minds Biosciences announces participation in upcoming scientific conferences and partnering events

Sep 19, 2024, 10:00 AM EDT - 1 year ago

Bright Minds Biosciences to Host Investor & Analyst KOL Event on September 25th

Sep 12, 2024, 8:00 AM EDT - 2 years ago

Bright Minds Biosciences Initiates the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy

Aug 14, 2024, 4:00 PM EDT - 2 years ago

Bright Minds Biosciences Registration statement: Q3 2024

Aug 14, 2024, 4:00 PM EDT - 2 years ago

Bright Minds Biosciences Registration statement: Q3 2024

May 15, 2024, 4:00 PM EDT - 2 years ago

Bright Minds Biosciences Registration statement: Q2 2024

May 15, 2024, 4:00 PM EDT - 2 years ago

Bright Minds Biosciences Registration statement: Q2 2024

Feb 12, 2024, 4:00 PM EST - 2 years ago

Bright Minds Biosciences Registration statement: Q1 2024

Feb 12, 2024, 4:00 PM EST - 2 years ago

Bright Minds Biosciences Registration statement: Q1 2024

Aug 8, 2023, 6:50 AM EDT - 3 years ago

Bright Minds Biosciences Announces Positive qEEG (Quantitative Electroencephalogram) Data from its First-in-Human Phase 1 Study of Lead Compound, BMB-101

Jul 20, 2023, 6:50 AM EDT - 3 years ago

Bright Minds Biosciences Announces Positive Topline Data for its First-in-Human Phase 1 Study of Lead Compound, BMB-101

Jul 12, 2023, 10:33 AM EDT - 3 years ago

CSE Bulletin: Consolidation - Bright Minds Biosciences Inc. (DRUG)

Jul 11, 2023, 6:50 AM EDT - 3 years ago

Bright Minds Announces Effective Date of Share Consolidation

Jun 22, 2023, 6:50 AM EDT - 3 years ago

Bright Minds Announces Proposed Share Consolidation

Apr 19, 2023, 6:50 AM EDT - 3 years ago

Bright Minds Biosciences Receives a Favorable Written Opinion from the International Searching Authority for BMB-202

Apr 10, 2023, 6:50 AM EDT - 3 years ago

Bright Minds Biosciences to Present at the 20th International Meeting of the International Society for Serotonin Research

Feb 27, 2023, 6:50 AM EST - 3 years ago

Bright Minds Biosciences Provides Clinical Program Updates and Outlines Anticipated Milestones for 2023

Feb 17, 2023, 6:50 AM EST - 3 years ago

Bright Minds Biosciences Announces Non-Executive Director Appointment

Feb 8, 2023, 4:05 PM EST - 3 years ago

Bright Minds Biosciences Announces Receipt of Nasdaq Deficiency Letter Regarding Independent Director and Audit Committee Requirements

Jan 27, 2023, 4:05 PM EST - 3 years ago

Bright Minds Biosciences Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

Jan 9, 2023, 4:05 PM EST - 3 years ago

Bright Minds Biosciences Announces Resignation of Board Member

Dec 2, 2022, 7:07 PM EST - 3 years ago

Bright Minds Biosciences Announces Closing of Non-Brokered Private Placement

Nov 28, 2022, 6:50 AM EST - 3 years ago

Bright Minds Biosciences Announces Non-Brokered Private Placement

Nov 23, 2022, 11:35 AM EST - 3 years ago

Bright Minds Biosciences Appoints Drug Development Executive Mark A. Smith M.D.

Sep 7, 2022, 6:50 AM EDT - 4 years ago

Bright Minds Biosciences Announces Appointment of Doug Williamson to Board of Directors

Aug 31, 2022, 6:50 AM EDT - 4 years ago

Bright Minds Biosciences Initiates Dosing in Phase I Clinical Trial of BMB-101 for Dravet Syndrome

Aug 30, 2022, 3:35 PM EDT - 4 years ago

Bright Minds Biosciences Announces Closing of $4 Million Unit Offering

Aug 23, 2022, 9:07 PM EDT - 4 years ago

Bright Minds Announces Pricing of Overnight Marketed Offering of Units

Aug 22, 2022, 7:05 PM EDT - 4 years ago

Bright Minds Announces Overnight Marketed Offering of Units

Aug 18, 2022, 3:34 PM EDT - 4 years ago

Bright Minds Biosciences Comments on Recent Trading Activity

Jun 27, 2022, 6:50 AM EDT - 4 years ago

Bright Minds Biosciences Announces Changes to its Executive Leadership Team, Marking the Transition to a Development Organization

May 12, 2022, 6:50 AM EDT - 4 years ago

Bright Minds Biosciences to Host Key Opinion Leader Symposium on Dravet Syndrome

May 2, 2022, 6:50 AM EDT - 4 years ago

Bright Minds Biosciences Establishes Scientific Advisory Board, Comprising Five Preeminent Physicians and Scientists Across Mental Health Specialties

Apr 19, 2022, 6:50 AM EDT - 4 years ago

Bright Minds Biosciences to Host Symposium on Therapeutic Developments within Dravet Syndrome and Featuring a Panel with Key Opinion Leaders

Mar 14, 2022, 6:50 AM EDT - 4 years ago

Bright Minds Biosciences Announces Successful Completion of 28-Day Toxicology Studies and Advancement to First-in-Human Clinical Trial

MavrickPete Sep. 7 at 8:32 PM

$DRUG need a bounce tomorrow

0 · Reply

Wody Sep. 2 at 11:39 PM

$ALLR next $DRUG run?!

1 · Reply

CoffeeRocks Sep. 1 at 9:35 PM

$SGLD $INHD $APUS $DRUG See under 10$ 🔜

0 · Reply

CoffeeRocks Aug. 31 at 5:22 PM

$AIFF buys are here $DRUG $INHD AIFF 1$ to $$$$

0 · Reply

mktrdr59 Aug. 29 at 10:45 PM

0 · Reply

JustAguysOpinion Aug. 27 at 12:07 AM

0 · Reply

ShawnDBG Aug. 25 at 12:36 AM

$DAIC $DRUG seems to think so

0 · Reply

theflynews Aug. 20 at 3:33 PM

Psychedelic: Enveric, Helus, Bright Minds report earnings results - $DRUG - https://thefly.com/DRUG

0 · Reply

JFDI Aug. 19 at 11:56 PM

0 · Reply

Doozio Aug. 19 at 10:00 PM

$DRUG zzzzz are next.

1 · Reply

Doozio Aug. 19 at 1:13 AM

$XBI so all da $DRUG zzzzzz

0 · Reply

CoffeeRocks Aug. 17 at 10:19 PM

$AIXI $BNAI $CXAI $AIFF AIFF same Will be interesting week $DRUG went from 1$ to 100$

0 · Reply

CoffeeRocks Aug. 17 at 8:27 PM

$AIXI $WETO $INHD Remember all big runners 🏃‍♂️ Started at 1$ $DRUG $HOLO

0 · Reply

npcpaperboy Aug. 17 at 8:18 PM

$DRUG news not enough vol to push

0 · Reply

Lowkeyoptions Aug. 15 at 4:03 PM

$TENX adding up the numbers from the sc 13G i get 20 million shares about hedgefund holdings as of last reporting August 14th. Imo that's very sizeable and if they took a dive down we're in for a wild ride. $CAPR $RGC $DRUG $PFE

0 · Reply

Lowkeyoptions Aug. 15 at 10:44 AM

$TENX watching bashers go bullish here is funny. Those 13g filings all dropped ah and i feel that was on purpose. Count up the millions held now plus company shares held. $CAPR $RGC $DRUG $PFE

1 · Reply

Lowkeyoptions Aug. 14 at 11:14 PM

$TENX 4 new 13G just dropped nothing left for retail 1.6 million 2.9 million 1.4 million 3.4 million 9 million 1.6 million Do the maths on this insider load Wtf!! 118 million in cash $CAPR $RGC $DRUG $PFE

1 · Reply

CoffeeRocks Aug. 12 at 4:27 PM

$GLND $DRUG $HOLO.X $RGC Lots of BiG move started from 1$

0 · Reply

jmcekc Aug. 12 at 1:00 PM

$DRUG Need some news. Let’s get visible again. Looking for big things in the remaining months of 2926.

0 · Reply

Doozio Aug. 12 at 12:48 AM

Chop chop huckleberries. All da $DRUG s DAVE as long as no faatch 💣

1 · Reply

mz08 Aug. 5 at 7:45 AM

$BJDX $GME $AMC $DRUG $SPRB

0 · Reply

CoffeeRocks Jul. 30 at 3:40 PM

$ZENA 660k volume $RTB $INHD $DRUG All started the run at 1$ Low volume Watchers are here Looking for buyers HERE and we go 🚀

0 · Reply

Market Cap	614.88M
Revenue (ttm)	0.00
Net Income (ttm)	-8.74M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	129,200
Avg Vol	179,024
Day's Range	N/A - N/A
Shares Out	9.73M
Stochastic %K	7%
Beta	-5.36
Analysts	Strong Sell
Price Target	$156.60